These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26654409)

  • 21. Treatment of delirium in the critically ill patient.
    Fish DN
    Clin Pharm; 1991 Jun; 10(6):456-66. PubMed ID: 1676622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A perspective on the management of delirium in terminally ill patients on a palliative care unit.
    Fainsinger RL; Tapper M; Bruera E
    J Palliat Care; 1993; 9(3):4-8. PubMed ID: 7903694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the role of hydration in delirium at the end of life.
    Galanakis C; Mayo NE; Gagnon B
    Curr Opin Support Palliat Care; 2011 Jun; 5(2):169-73. PubMed ID: 21532351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Pharmacotherapy Does Not Improve Severity of Hypoactive Delirium in Patients with Advanced Cancer: Pharmacological Audit Study of Safety and Efficacy in Real World (Phase-R).
    Okuyama T; Yoshiuchi K; Ogawa A; Iwase S; Yokomichi N; Sakashita A; Tagami K; Uemura K; Nakahara R; Akechi T;
    Oncologist; 2019 Jul; 24(7):e574-e582. PubMed ID: 30610009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
    van Eijk MM; Roes KC; Honing ML; Kuiper MA; Karakus A; van der Jagt M; Spronk PE; van Gool WA; van der Mast RC; Kesecioglu J; Slooter AJ
    Lancet; 2010 Nov; 376(9755):1829-37. PubMed ID: 21056464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosing and Managing Delirium in Cancer Patients.
    Edelstein A; Alici Y
    Oncology (Williston Park); 2017 Sep; 31(9):686-692, III. PubMed ID: 29071696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differing management of people with advanced cancer and delirium by four sub-specialties.
    Agar M; Currow D; Plummer J; Chye R; Draper B
    Palliat Med; 2008 Jul; 22(5):633-40. PubMed ID: 18612029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How is agitation and restlessness managed in the last 24 h of life in patients whose care is supported by the Liverpool care pathway for the dying patient?
    Gambles M; McGlinchey T; Latten R; Dickman A; Lowe D; Ellershaw JE
    BMJ Support Palliat Care; 2011 Dec; 1(3):329-33. PubMed ID: 24653479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should Neuroleptics Be Used in Patients With Delirium Seen by Palliative Care?
    Hui D; Agar M; Maeda I
    J Pain Symptom Manage; 2023 Jan; 65(1):e81-e85. PubMed ID: 36220457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic prescribing patterns, and the factors and outcomes associated with their use, among patients requiring prolonged mechanical ventilation in the long-term acute care hospital setting.
    Al-Qadheeb NS; O'Connor HH; White AC; Neidhardt A; Albizati M; Joseph B; Roberts RJ; Ruthazer RR; Devlin JW
    Ann Pharmacother; 2013 Feb; 47(2):181-8. PubMed ID: 23386064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of terminal restlessness: a review of the evidence.
    Kehl KA
    J Pain Palliat Care Pharmacother; 2004; 18(1):5-30. PubMed ID: 15148006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential role of zuclopenthixol acetate in the management of refractory hyperactive delirium at the end of life.
    Tarumi Y; Watanabe S
    J Pain Symptom Manage; 2008 Apr; 35(4):336-9. PubMed ID: 18291620
    [No Abstract]   [Full Text] [Related]  

  • 33. [Delirium in palliative care].
    Loge JH; Hjermstad MJ; Kaasa S
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):616-9. PubMed ID: 16505874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propofol in terminal care.
    Mercadante S; De Conno F; Ripamonti C
    J Pain Symptom Manage; 1995 Nov; 10(8):639-42. PubMed ID: 8594125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics of haloperidol in terminally ill adult patients.
    Franken LG; Mathot RAA; Masman AD; Baar FPM; Tibboel D; van Gelder T; Koch BCP; de Winter BCM
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1271-1277. PubMed ID: 28681176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Pharmacological Treatments for Agitated Delirium in the Last Days of Life.
    Kawashima N; Yokomichi N; Morita T; Yabuki R; Hisanaga T; Imai K; Hirose Y; Shimokawa M; Miwa S; Yamauchi T; Okamoto S; Satomi E
    J Pain Symptom Manage; 2024 May; 67(5):441-452.e3. PubMed ID: 38355071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.
    Devlin JW; Roberts RJ; Fong JJ; Skrobik Y; Riker RR; Hill NS; Robbins T; Garpestad E
    Crit Care Med; 2010 Feb; 38(2):419-27. PubMed ID: 19915454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Terminal delirium: families' experience.
    Namba M; Morita T; Imura C; Kiyohara E; Ishikawa S; Hirai K
    Palliat Med; 2007 Oct; 21(7):587-94. PubMed ID: 17942497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients.
    Miyaji S; Yamamoto K; Hoshino S; Yamamoto H; Sakai Y; Miyaoka H
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):275-82. PubMed ID: 17472596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.